{"title":"Using three-dimensional virtual imaging of renal masses to improve prediction of robotic-assisted partial nephrectomy Tetrafecta with SPARE score.","authors":"HaoXiang Huang, Bohong Chen, Cong Feng, Wei Chen, Dapeng Wu","doi":"10.1007/s00345-024-05344-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To improve the predictability of outcomes in robotic-assisted partial nephrectomy, we utilized three-dimensional virtual imaging for SPARE nephrometry scoring. We compared this method with a conventional two-dimensional scoring system to determine whether 3D virtual images offer enhanced predictive accuracy for Tetrafecta outcomes.</p><p><strong>Methods: </strong>We retrospectively collected basic information, demographic data, and perioperative indices from patients who underwent robot-assisted partial nephrectomy for renal masses at the Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University. A three-dimensional visualization system (IPS system, Yorktal) was employed to reconstruct the patients' imaging data using AI-based automatic segmentation, resulting in a three-dimensional visualization model (3DVM). This model was then imported into the virtual surgical planning software (Touch Viewer System, Yorktal) for automatic measurement of the SPARE score. Tetrafecta was defined as a warm ischemic time (WIT) of less than 25 min, negative surgical margins, absence of major perioperative complications, and no decline in postoperative renal function. The receiver operating characteristic (ROC) curve was utilized to evaluate the sensitivity and specificity of the SPARE score.</p><p><strong>Results: </strong>A total of 141 patients were included in this study, with a mean age of 55.6 ± 11.14 years and a mean tumor size of 3.5 ± 1.2 cm. All variables, except for estimated blood loss (EBL) (Coefficient = 0.056, 0.035; P = 0.514, 0.685), showed significant correlation with the SPARE score when comparing CT and 3D virtual models (Tetrafecta: Coefficient = 0.408, 0.56; P < 0.001, < 0.001; WIT: Coefficient = 0.340, 0.237; P < 0.001, 0.007; ΔeGFR: Coefficient = 0.212, 0.257; P = 0.012, 0.002). The area under the curve (AUC) values from the ROC curves indicated that the 3D virtual model group had significantly better performance than the 2D image group for the SPARE score. However, there was no significant difference in the ROC curves for the SPARE complexity category between the two imaging modalities (AUC for SPARE category with 3DVM = 0.658 vs. AUC for SPARE category with CT = 0.643, P = 0.59; AUC for SPARE score with 3DVM = 0.854 vs. AUC for SPARE score with CT = 0.755, P < 0.001).</p><p><strong>Conclusions: </strong>The SPARE score combined with 3DVM has a more accurate predictive ability for Tetrafecta of RAPN compared to the traditional 2D SPARE score.</p>","PeriodicalId":23954,"journal":{"name":"World Journal of Urology","volume":"43 1","pages":"37"},"PeriodicalIF":2.8000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00345-024-05344-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To improve the predictability of outcomes in robotic-assisted partial nephrectomy, we utilized three-dimensional virtual imaging for SPARE nephrometry scoring. We compared this method with a conventional two-dimensional scoring system to determine whether 3D virtual images offer enhanced predictive accuracy for Tetrafecta outcomes.
Methods: We retrospectively collected basic information, demographic data, and perioperative indices from patients who underwent robot-assisted partial nephrectomy for renal masses at the Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University. A three-dimensional visualization system (IPS system, Yorktal) was employed to reconstruct the patients' imaging data using AI-based automatic segmentation, resulting in a three-dimensional visualization model (3DVM). This model was then imported into the virtual surgical planning software (Touch Viewer System, Yorktal) for automatic measurement of the SPARE score. Tetrafecta was defined as a warm ischemic time (WIT) of less than 25 min, negative surgical margins, absence of major perioperative complications, and no decline in postoperative renal function. The receiver operating characteristic (ROC) curve was utilized to evaluate the sensitivity and specificity of the SPARE score.
Results: A total of 141 patients were included in this study, with a mean age of 55.6 ± 11.14 years and a mean tumor size of 3.5 ± 1.2 cm. All variables, except for estimated blood loss (EBL) (Coefficient = 0.056, 0.035; P = 0.514, 0.685), showed significant correlation with the SPARE score when comparing CT and 3D virtual models (Tetrafecta: Coefficient = 0.408, 0.56; P < 0.001, < 0.001; WIT: Coefficient = 0.340, 0.237; P < 0.001, 0.007; ΔeGFR: Coefficient = 0.212, 0.257; P = 0.012, 0.002). The area under the curve (AUC) values from the ROC curves indicated that the 3D virtual model group had significantly better performance than the 2D image group for the SPARE score. However, there was no significant difference in the ROC curves for the SPARE complexity category between the two imaging modalities (AUC for SPARE category with 3DVM = 0.658 vs. AUC for SPARE category with CT = 0.643, P = 0.59; AUC for SPARE score with 3DVM = 0.854 vs. AUC for SPARE score with CT = 0.755, P < 0.001).
Conclusions: The SPARE score combined with 3DVM has a more accurate predictive ability for Tetrafecta of RAPN compared to the traditional 2D SPARE score.
期刊介绍:
The WORLD JOURNAL OF UROLOGY conveys regularly the essential results of urological research and their practical and clinical relevance to a broad audience of urologists in research and clinical practice. In order to guarantee a balanced program, articles are published to reflect the developments in all fields of urology on an internationally advanced level. Each issue treats a main topic in review articles of invited international experts. Free papers are unrelated articles to the main topic.